Muna Therapeutics
Muna Therapeutics is a biopharmaceutical company focused on discovering and developing therapies that slow or stop neurodegenerative diseases such as Alzheimer's and Parkinson's. Their approach integrates human genetics, bioinformatics, and cell biology to develop first-in-class small molecule drugs that resolve neuroinflammation and normalize microglia function. The company leverages AI-driven computational chemistry and high-resolution protein structural methods in their drug discovery engine. Muna Therapeutics aims to preserve cognition and brain function, enhancing resilience to disease pathology, addressing a large unmet medical need affecting over 200 million patients worldwide. They have strategic alliances and funding support from notable foundations and investors, positioning them as a promising player in neurodegenerative disease therapeutics.
Muna Therapeutics
Muna Therapeutics is a biopharmaceutical company focused on discovering and developing therapies that slow or stop neurodegenerative diseases such as Alzheimer's and Parkinson's. Their approach integrates human genetics, bioinformatics, and cell biology to develop first-in-class small molecule drugs that resolve neuroinflammation and normalize microglia function. The company leverages AI-driven computational chemistry and high-resolution protein structural methods in their drug discovery engine. Muna Therapeutics aims to preserve cognition and brain function, enhancing resilience to disease pathology, addressing a large unmet medical need affecting over 200 million patients worldwide. They have strategic alliances and funding support from notable foundations and investors, positioning them as a promising player in neurodegenerative disease therapeutics.